Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EOIP vs OSTAP vs Infiltration in Laparoscopic Cholecystectomy
NCT06326281Active, not recruiting
- Sponsor
- Ankara City Hospital
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (4 arms), sponsored by Ankara City Hospital. Primary endpoints: Amount of postoperative opioid use at 24 hours and Numerical Rating Scale Score at 24 hours. Started Mar 2024; status: active, not recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06326281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06326281.